Does ofloxacin protect against BCG-related toxic effects in patients with bladder cancer?
- 10 April 2007
- journal article
- editorial
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 4 (6) , 304-305
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- INTRAVESICAL INSTILLATION OF EPIRUBICIN, BACILLUS CALMETTE-GUERIN AND BACILLUS CALMETTE-GUERIN PLUS ISONIAZID FOR INTERMEDIATE AND HIGH RISK TA, T1 PAPILLARY CARCINOMA OF THE BLADDER: A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER GENITO-URINARY GROUP RANDOMIZED PHASE III TRIALJournal of Urology, 2001
- BLADDER CANCER CLINICAL GUIDELINES PANEL SUMMARY REPORT ON THE MANAGEMENT OF NONMUSCLE INVASIVE BLADDER CANCER (STAGES Ta, T1 AND TIS)Journal of Urology, 1999
- The Quality of Life During Intravesical Bacillus Calmette-Guerin TherapyJournal of Urology, 1996